May 26 (Reuters) - Hofseth Biocare ASA HOFBC.OL :
* Board of Directors decided to withdraw its proposal for subsequent offering
* Says the company's existing shareholders have been able to neutralize dilutive effect of
share issue, which was adopted on April 22, by buying shares in open market at price below
subscription price of 2.00 Norwegian crowns per share
Source text for Eikon: ID:nHUGc5BY8X
Further company coverage: HOFBC.OL
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))